Beck Bode, LLC Novartis Ag Transaction History

Beck Bode, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$94.73 - $105.13 $419,180 - $465,200	4,425 Added 10.46%	46,736 $4.76 Million
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $3.91 Million - $4.44 Million	42,311 New	42,311 $4.27 Million
Q2 2022 Jul 29, 2022	SELL	$80.52 - $93.75 $22,626 - $26,343	-281 Reduced 10.32%	2,441 $206,000
Q1 2022 May 02, 2022	BUY	$80.11 - $90.62 $218,059 - $246,667	2,722 New	2,722 $239,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.